Atticus Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400
| Closed | -$13.5K | – | 526 |
|
|
2024
Q4 | $13.5K | Hold |
400
| – | – | ﹤0.01% | 366 |
|
|
2024
Q3 | $16.4K | Hold |
400
| – | – | 0.01% | 349 |
|
|
2024
Q2 | $15.4K | Hold |
400
| – | – | 0.01% | 338 |
|
|
2024
Q1 | $17.1K | Hold |
400
| – | – | 0.01% | 342 |
|
|
2023
Q4 | $14.8K | Hold |
400
| – | – | 0.01% | 360 |
|
|
2023
Q3 | $14.5K | Hold |
400
| – | – | 0.01% | 363 |
|
|
2023
Q2 | $14.3K | Hold |
400
| – | – | 0.01% | 368 |
|
|
2023
Q1 | $14.2K | Sell |
400
-286
| -42% | -$10.2K | 0.01% | 354 |
|
|
2022
Q4 | $24.1K | Sell |
686
-530
| -44% | -$18.6K | 0.01% | 319 |
|
|
2022
Q3 | $53K | Buy |
1,216
+243
| +25% | +$10.6K | 0.03% | 226 |
|
|
2022
Q2 | $53K | Hold |
973
| – | – | 0.02% | 246 |
|
|
2022
Q1 | $53K | Buy |
973
+400
| +70% | +$21.8K | 0.02% | 241 |
|
|
2021
Q4 | $32K | Sell |
573
-400
| -41% | -$22.3K | 0.01% | 273 |
|
|
2021
Q3 | $46K | Sell |
973
-286
| -23% | -$13.5K | 0.02% | 244 |
|
|
2021
Q2 | $63K | Hold |
1,259
| – | – | 0.03% | 209 |
|
|
2021
Q1 | $56K | Hold |
1,259
| – | – | 0.03% | 202 |
|
|
2020
Q4 | $58K | Hold |
1,259
| – | – | 0.03% | 198 |
|
|
2020
Q3 | $59K | Hold |
1,259
| – | – | 0.04% | 165 |
|
|
2020
Q2 | $64K | Hold |
1,259
| – | – | 0.04% | 158 |
|
|
2020
Q1 | $60K | Sell |
1,259
-16
| -1% | -$763 | 0.05% | 160 |
|
|
2019
Q4 | $75K | Buy |
+1,275
| New | +$75K | 0.05% | 150 |
|